Transplantation Proceedings
Volume 33, Issue 1 , Page 80 , February 2001

Intrathymic immune regulation with donor class I allopeptides leads to the development of immunoregulatory cells that maintain tolerance to cardiac allografts

  • H Shirwan

      Affiliations

    • Institute for Cellular Therapeutics, University of Louisville (H.S., A.M., E.Y.), Louisville, Kentucky, USA
    • Dianon System Incorporation (S.I.), Stratford, Connecticut, USA
    • Corresponding Author InformationAddress reprint requests to Dr H. Shirwan, Institute for Cellular Therapeutics, University of Louisville, 570 S Preston Street, Suite 404, Louisville, KY 40202
    • ,
  • A Mhoyan

      Affiliations

    • Institute for Cellular Therapeutics, University of Louisville (H.S., A.M., E.Y.), Louisville, Kentucky, USA
    • Dianon System Incorporation (S.I.), Stratford, Connecticut, USA
    • ,
  • E Yolcu

      Affiliations

    • Institute for Cellular Therapeutics, University of Louisville (H.S., A.M., E.Y.), Louisville, Kentucky, USA
    • Dianon System Incorporation (S.I.), Stratford, Connecticut, USA
    • ,
  • S Ibrahim

      Affiliations

    • Institute for Cellular Therapeutics, University of Louisville (H.S., A.M., E.Y.), Louisville, Kentucky, USA
    • Dianon System Incorporation (S.I.), Stratford, Connecticut, USA

References 

  1. Shirwan H. Transplantation. 1999;68:715
  2. Mhoyan A, Cramer DV, Baquerizo A, et al.  Transplantation. 1997;64:1665
  3. Shirwan H, Wu GD, Barwari L, et al.  Transplantation. 1997;64:1671
  4. Shirwan H, Chi DL, Makowka L, et al.  J Immunol. 1993;151:5228

☆ Supported by grants to H.S. from NIH (AI 33587) and AHA (9650229N and 9951499V).

PII: S0041-1345(00)01912-6

Transplantation Proceedings
Volume 33, Issue 1 , Page 80 , February 2001

Article Tools